Immunological Mechanisms of Paraneoplastic Nervous System Diseases

  • B. Giometto
  • P. Nicolao
  • T. Scaravilli
  • M. Vianello
  • B. Vitaliani
  • A. M. Ferrarini
  • B. Tavolato
Part of the Topics in Neuroscience book series (TOPNEURO)


The term “paraneoplastic neurological diseases” (PND) (also known as “remote neurological effect of cancer”) encompasses a wide group of disorders associated with systemic malignancies which, in order to fulfil the criteria for the definition of this disorder, must not directly invade, compress or metastasise to the nervous system.


Purkinje Cell Cerebellar Degeneration Paraneoplastic Cerebellar Degeneration Antineuronal Antibody Purkinje Cell Degeneration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Henson RA, Urich H (1982) Cancer and the Nervous System. Blackwell Scientific, OxfordGoogle Scholar
  2. 2.
    Greenfield JG (1934) Subacute spinocerebellar degeneration occurring in elderly patients. Brain 57:161–176CrossRefGoogle Scholar
  3. 3.
    Henson RA, Russell DS, Wilkinson M (1954) Carcinomatous neuropathy and myopathy. A clinical and pathological study. Brain 77:82–121PubMedCrossRefGoogle Scholar
  4. 4.
    Henson RA, Hoffman HL, Urich H (1965) Encephalomyelitis with carcinoma. Brain 88:449–464PubMedCrossRefGoogle Scholar
  5. 5.
    Denny-Brown D (1948) Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiat 11:73–87PubMedCrossRefGoogle Scholar
  6. 6.
    Posner JB (1995) Paraneoplastic syndromes. In: Posner JB (ed) Neurologic complication of cancer. Davis, Philadelphia, pp 353–383. (Contemporary Neurology series 45)Google Scholar
  7. 7.
    Giometto B, Tavolato B, Graus F (1999) Autoimmunity in paraneoplastic neurological disorders. Brain Pathol 9:261–273PubMedCrossRefGoogle Scholar
  8. 8.
    Russell Brain W, Daniel PM, Greenfield JG (1951) Subacute cortical cerebellar degeneration and its relation to carcinoma. J Neurol Neurosurg Psychiatry 14:59–75CrossRefGoogle Scholar
  9. 9.
    Wilkinson PC, Zeromski J (1965) Immunofluorescent detection of antibodies against neurons in sensory carcinomatous neuropathy. Brain 88:529–538PubMedCrossRefGoogle Scholar
  10. 10.
    Trotter JL, Hendin BA, Osterland CK (1976) Cerebellar degeneration with Hodgkin’s disease. Arch Neurol 33:660–661PubMedCrossRefGoogle Scholar
  11. 11.
    Greenlee JE, Brashear HR (1983) Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 14:609–613PubMedCrossRefGoogle Scholar
  12. 12.
    Sakai K, Mitchell DJ, Tsukamoto T, Steinman L (1990) Isolation of a cDNA clone encoding an autoantigen recognised by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration (cloning of the PCD-17 autoantigen). Ann Neurol 28:692–698PubMedCrossRefGoogle Scholar
  13. 13.
    Fatallah-Shaykh H, Wolf S, Wong E et al (1991) Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci USA 88:3451–3545CrossRefGoogle Scholar
  14. 14.
    Sakai K, Negami T, Yoshioka A, Hirose G (1992) The expression of a cerebellar degeneration-associated neural antigen in human tumor line cells. Neurology 42:361–366PubMedCrossRefGoogle Scholar
  15. 15.
    Furneaux HM, Rosenblum MK, Dalmau J et al (1990) Selective expression of Purkinjecell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 227:1844–1851CrossRefGoogle Scholar
  16. 16.
    Szabo A, Dalmau J, Manley G et al (1991) HuD a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67:325–333PubMedCrossRefGoogle Scholar
  17. 17.
    Sakai K, Gofuku M, Kitagawa Y et al (1994) A hippocampal protein associated with paraneoplastic neurologic syndrome and small cell lung carcinoma. Bioch Biophys Res Commun 199:1200–1208CrossRefGoogle Scholar
  18. 18.
    King PH (1994) Hel-N2: a novel isoform of Hel-N1 which is conserved in rat neural tissue and produced in early embryogenesis. Gene 151:261–265PubMedCrossRefGoogle Scholar
  19. 19.
    King PH, Dropcho EJ (1996) Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma. Ann Neurol 39:679–681PubMedCrossRefGoogle Scholar
  20. 20.
    Sekido Y, Bader SA, Carbone DP et al (1994) Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines. Cancer Res 54:4988–4992PubMedGoogle Scholar
  21. 21.
    Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB (1992) The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in normal and tumor tissues. Am J Pathol 141:881–886PubMedGoogle Scholar
  22. 22.
    King PH, Levine TD, Fremeau RT Jr, Keene JD (1994) Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3° UTR of mRNA encoding the Id transcriptional repressor. J Neurosci 14:1943–1952PubMedGoogle Scholar
  23. 23.
    Liu J, Dalmau J, Szabo A et al (1995) Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA. Neurology 45:544–550PubMedCrossRefGoogle Scholar
  24. 24.
    Marusich MF, Weston JA (1992) Identification of early neurogenic cells in the normal crest lineage. Dev Biol 149:295–306PubMedCrossRefGoogle Scholar
  25. 25.
    Luque FA, Furneaux HM, Ferziger R et al (1991) Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 29:241–251PubMedCrossRefGoogle Scholar
  26. 26.
    Buckanovich RJ, Posner JB, Darnell RB (1993) Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron 11:657–672PubMedCrossRefGoogle Scholar
  27. 27.
    Lang B, Newsom-Davies J, Prior C, Wray D (1983) Autoimmune aetiology for myasthenic (Eaton Lambert) syndrome. Lancet ii:224–226Google Scholar
  28. 28.
    Leys K, Lang B, Johnston I, Newsom-Davies J (1991) Calcium channel autoantibodies in the Lambert-Eaton myastenic syndrome. Ann Neurol 29:307–314PubMedCrossRefGoogle Scholar
  29. 29.
    Lennon VA (1996) Calcium channel and related paraneoplastic disease autoantibodies. In: Peter JB, Shoenfeld Y (eds) Autoantibodies. Elsevier Science, Amsterdam, pp 139–147CrossRefGoogle Scholar
  30. 30.
    Sillevis-Smitt PAE, Manley GT, Posner JB (1994) High titer antibodies but no disease in mice immunized with the paraneoplastic antigen HuD. Neurology 43:2049–2054Google Scholar
  31. 31.
    Hormigo A, Lieberman F (1994) Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity. J Neuroimmunol 55:205–212PubMedCrossRefGoogle Scholar
  32. 32.
    Greenlee JE, Parks TN, Jaeckle KA (1993) Type la (“anti-Hu”) antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro. Neurology 43:2049–2054PubMedCrossRefGoogle Scholar
  33. 33.
    Verschuuren JJ, Dalmau J, Hoard R, Posner JB (1997) Paraneoplastic anti-Hu serum: studies on human tumor cell lines. J Neuroimmunol 79:202–205PubMedCrossRefGoogle Scholar
  34. 34.
    Dalmau J, Graus F, Rosenblum MK, Posner JB (1991) Detection of the anti-Hu anti-body in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuropathy. Neurology 41:1757–1764PubMedCrossRefGoogle Scholar
  35. 35.
    Graus F, Elkon KB, Cordon-Cardo C, Posner JB (1986) Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med 80:45–52PubMedCrossRefGoogle Scholar
  36. 36.
    René R, Ferrer I, Graus F (1996) Clinical and immunohistochemical comparison of in vivo injected anti-Hu and control IgG in the nervous system of the mouse. Eur J Neurol 3:319–323CrossRefGoogle Scholar
  37. 37.
    Giometto B, Marchiori GC, Nicolao P et al (1997) Subacute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol Appl Neurobiol 23:468–474PubMedCrossRefGoogle Scholar
  38. 38.
    Verschuuren JJ, Chuang L, Rosenblum MK et al (1996) Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol (Berl) 91:519–525CrossRefGoogle Scholar
  39. 39.
    Greenlee JE, Burns JB, Rose JW et al (1995) Uptake of systemically administered human cerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Acta Neuropathol 89:341–345PubMedCrossRefGoogle Scholar
  40. 40.
    Graus F, Ilia I, Agusti M et al (1991) Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J Neurol Sci 106:82–87PubMedCrossRefGoogle Scholar
  41. 41.
    Tanaka M, Tanaka K, Onodera O, Tsuji S (1995) Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. Clin Neurol Neurosurg 97:95–100PubMedCrossRefGoogle Scholar
  42. 42.
    Tanaka K, Tanaka K, Igarashi S et al (1995) Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Clin Neurol Neurosurg 97:101–105PubMedCrossRefGoogle Scholar
  43. 43.
    Scaravilli F, An SF, Groves M, Thom M (1999) The neuropathology of paraneoplastic syndromes. Brain Pathol 9:251–260PubMedCrossRefGoogle Scholar
  44. 44.
    Voltz R, Dalmau J, Posner JB, Rosenfeldt MR (1998) T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 51:1146–1150PubMedCrossRefGoogle Scholar
  45. 45.
    Dalmau J, Graus F, Cheung NK et al (1995) Major histocompatibilility proteins, anti-Hu antibodies and paraneoplastic encephalolomyelitis in neuroblastoma and small cell lung cancer. Cancer 75:99–109PubMedCrossRefGoogle Scholar
  46. 46.
    Albert ML, Austin LM, Darnell RB (2000) Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 47:9–17PubMedCrossRefGoogle Scholar
  47. 47.
    Albert ML, Darnell JC, Bender A et al (1998) Tumor-specific killer cells in paraneo-plastic cerebellar degeneration. Nature Med 4:1321–1324PubMedCrossRefGoogle Scholar
  48. 48.
    Neumann H, Cavalié A, Jenne DE, Wekerle H (1995) Induction of MHC class I genes in neurons. Science 269:549–552PubMedCrossRefGoogle Scholar
  49. 49.
    Corriveaux RA, Huh GS, Shatz CJ (1998) Regulation of class I MHC gene expression in the developing and mature CNS of neural activity. Neuron 21:505–520CrossRefGoogle Scholar
  50. 50.
    Darnell RB (1996) Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci USA 93:4529–4536PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2002

Authors and Affiliations

  • B. Giometto
    • 1
  • P. Nicolao
    • 1
  • T. Scaravilli
    • 1
  • M. Vianello
    • 1
  • B. Vitaliani
    • 1
  • A. M. Ferrarini
    • 1
  • B. Tavolato
    • 1
  1. 1.Department of Neurologic and Psychiatric Sciences, Second Neurological ClinicUniversity of PaduaPaduaItaly

Personalised recommendations